Side-by-side · Research reference
EpitalonvsPinealon
Side-by-side comparison across mechanism, dosage, evidence, side effects, administration, and stack synergies. Citations on every claim where available.
AHuman-MechanisticDraft8/37 cited
BHuman-MechanisticDraft12/36 cited
Epitalon
Pineal bioregulator · Telomerase activator
SQ or IM · Abdomen · Daily for 10–20 days
Pinealon
Pineal-derived · Neuroprotective
SQ or IM · Daily for 10 days · 1-2×/year
01Mechanism of Action
Parameter
Epitalon
Pinealon
Primary target
Telomerase activity (proposed); pineal melatonin axis modulationKhavinson 2003
Antioxidant defense + neuronal gene expression (proposed)Khavinson 2014
Pathway
Activation of telomerase reverse transcriptase (hTERT) in somatic cells; pineal-axis modulation supports endogenous melatoninKhavinson 2003
Modulation of antioxidant enzymes (SOD, catalase) + neurotrophic factor expressionKhavinson 2014
Downstream effect
Telomere elongation, improved sleep architecture, reported lifespan extension in aged miceKhavinson 2003
Reduced oxidative stress in neurons; improved cognitive function in age-related declineKhavinson 2014
Feedback intact?
—
—
Origin
Synthetic 4-AA peptide derived from epithalamin (a natural pineal extract)Khavinson 2003
Synthetic 4-AA peptide derived from pineal gland extractKhavinson 2014
Antibody development
—
—
02Dosage Protocols
Parameter
Epitalon
Pinealon
Standard dose
5–10 mg / day for 10–20 days, 1–2× per yearKhavinson 2003
Anecdotal community protocol. Russian clinical literature uses similar cycling.
5–10 mg / day for 10 daysKhavinson 2014
Frequency
Once daily during a cycle
Once daily during cycle
Lower / starter dose
2.5 mg / day
2.5 mg / day
Evidence basis
In-vitro telomerase + Russian clinical trialsKhavinson 2003
Russian clinical trials + in vitroKhavinson 2014
Duration
10–20 day cycles, 1–2× per year
10-day cycles, 1–2× per year
Reconstitution
Bacteriostatic water
Bacteriostatic water
Timing
Pre-sleep preferred (pineal alignment)
No specific time
Half-life
Hours (estimated)
Hours
04Side Effects & Safety
Parameter
Epitalon
Pinealon
Injection site reaction
Mild irritation
Mild irritation
Sleep architecture
Improved subjective sleep quality (anecdotal)
—
Cancer risk
Theoretical via telomerase activation in pre-malignant cells
—
Long-term safety
Limited Western RCT data
Limited Western data
Pregnancy / OB
Avoid
Avoid
Antibody formation
Not reported
—
Absolute Contraindications
Epitalon
- ·Pregnancy / breastfeeding
- ·Active malignancy or pre-malignant state
Pinealon
- ·Pregnancy / breastfeeding
Relative Contraindications
Epitalon
- ·Family history of cancer
Pinealon
- ·Active malignancy (theoretical via gene expression modulation)
05Administration Protocol
Parameter
Epitalon
Pinealon
1. Reconstitution
Add 1–2 mL bacteriostatic water to 10 mg vial → 5–10 mg/mL.
Add 1–2 mL bacteriostatic water to 10 mg vial.
2. Injection site
SQ — abdomen preferred. Rotate sites.
SQ — abdomen preferred.
3. Timing
Pre-sleep preferred to align with pineal axis.
Daily during cycle, any time.
4. Storage
Lyophilised: room temp, light-protected. Reconstituted: refrigerate ≤30 days.
Lyophilised: room temp. Reconstituted: refrigerate ≤30 days.
5. Needle
29–31G, 4–8 mm insulin syringe.
29–31G, 4–8 mm insulin syringe.
06Stack Synergy
Epitalon
— no documented stacks
Pinealon
+ Epitalon
ModeratePinealon (neuroprotection) + Epitalon (telomerase activation) form the canonical Khavinson "longevity stack" — both pineal-derived bioregulators with complementary axes. Pinealon supports neuronal antioxidant defense; Epitalon supports telomere maintenance. Anecdotally cycled together 1–2× per year.
- Pinealon
- 5–10 mg SQ · daily × 10 days
- Epitalon
- 5–10 mg SQ · daily × 10 days (overlap or alternate)
- Primary benefit
- Neuroprotection + telomere preservation